News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alkermes plc (ALKS) Reports Second Quarter 2014 Financial Results


7/31/2014 10:38:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Alkermes plc (NASDAQ: ALKS) today reported financial results for the second quarter of 2014.

“These quarterly results reflect the strength of our commercial business and the progress we are making to advance Alkermes’ pipeline of innovative CNS medicines. We expect this valuable, late-stage pipeline to fuel significant future growth, and we are in the strong position to drive new product development with robust and reliable revenue streams and significant cash on the balance sheet,” commented James Frates, Chief Financial Officer of Alkermes.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES